Literature DB >> 9156045

The basal rate of cell proliferation in normal human parathyroid tissue: implications for the pathogenesis of hyperparathyroidism.

Q Wang1, S Palnitkar, A M Parfitt.   

Abstract

BACKGROUND: The basal rate of cell proliferation in the human parathyroid gland is generally believed to be low, but has never previously been measured directly, although, as in other tissues, it is relevant to the pathogenesis of neoplasia.
METHODS: We retrieved embedded tissue blocks of parathyroids removed at autopsy from 39 patients without hypercalcaemia or abnormal renal function, aged 18 to 76 years (mean 47.6). New sections were cut and examined for expression of Ki-67, a cell-cycle marker, using the MIB-1 antibody with microwave antigen retrieval, and tonsil as positive control. Using an eyepiece graticule with unbiased square-counting frame, positively labelled chief cells were counted in large squares and total chief cells in small squares in fields selected by systematic random sampling from multiple regions. A minimum of 15 x 10(3) chief cells were accumulated in each case. The prevalence of Ki-67 positive cells per 10(4) cells (label index or LI) was converted to cell birth rate assuming that the duration of Ki-67 expression was 24 hours. In ten cases, the entire section was examined; a map of the distribution of the positive cells was reconstructed, and divided into outer and inner regions.
RESULTS: The geometric mean value for LI was 1.44/ 10(4), and multiplicative SD 2.54. The corresponding geometric mean cell-birth rate was 5.24%/year and 95% confidence interval 0.81-33.8%/year. We found no significant effect of age, sex, race, or duration of tissue storage. The distribution of cells conformed to a Poisson distribution, and there was no difference between central and peripheral regions.
CONCLUSIONS: (1) Our results establish the human parathyroid gland as a conditionally renewing tissue with very low basal cell-birth rate; other reports of much higher LI values are probably due to selective and consequently biased sampling. (2) Since the total number of cell divisions is a major determinant of the total number of mutations, our results place some constraints of possible mechanisms for parathyroid neoplasia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9156045     DOI: 10.1046/j.1365-2265.1997.1420959.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  9 in total

Review 1.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

2.  NF-κB activation contributes to parathyroid cell proliferation in chronic kidney disease.

Authors:  Sen Kan; Weichen Zhang; Jianping Mao; Mengjing Wang; Li Ni; Minmin Zhang; Qian Zhang; Jing Chen
Journal:  J Nephrol       Date:  2018-08-31       Impact factor: 3.902

3.  Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.

Authors:  Qian Zhang; Junsi Qiu; Haiming Li; Yanwen Lu; Xiaoyun Wang; Junwei Yang; Shaoqing Wang; Liyin Zhang; Yong Gu; Chuan-Ming Hao; Jing Chen
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

4.  Parathyroid-specific epidermal growth factor-receptor inactivation prevents uremia-induced parathyroid hyperplasia in mice.

Authors:  Maria Vittoria Arcidiacono; Jing Yang; Elvira Fernandez; Adriana Dusso
Journal:  Nephrol Dial Transplant       Date:  2014-10-16       Impact factor: 5.992

5.  Expression of parathyroid-specific genes in vascular endothelial progenitors of normal and tumoral parathyroid glands.

Authors:  Sabrina Corbetta; Marzia Belicchi; Federica Pisati; Mirella Meregalli; Cristina Eller-Vainicher; Leonardo Vicentini; Paolo Beck-Peccoz; Anna Spada; Yvan Torrente
Journal:  Am J Pathol       Date:  2009-07-30       Impact factor: 4.307

6.  p53/MDM2 Pathway Aberrations in Parathyroid Tumors: p21(WAF-1) and MDM2 Are Frequently Overexpressed in Parathyroid Adenomas.

Authors:  Begona Arribas; Eva Cristobal; Jose A. Alcazar; Juan Tardio; Juan C. Matinez-Montero; Jose R. Polo; Rafael Carrion; Laura Gil; Marta Azanedo; Jose M. Rojas; Javier Menarguez
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 7.  Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool.

Authors:  A Galassi; A Cupisti; A Santoro; M Cozzolino
Journal:  J Nephrol       Date:  2014-09-23       Impact factor: 3.902

8.  Pathophysiology of parathyroid hyperplasia in chronic kidney disease: preclinical and clinical basis for parathyroid intervention.

Authors:  Shunsuke Goto; Hirotaka Komaba; Masafumi Fukagawa
Journal:  NDT Plus       Date:  2008-08

9.  Expression of p53, Ki67, epidermal growth factor receptor, transforming growth-factorα, and p21 in primary and secondary hyperparathyroidism.

Authors:  Saime Paydas; Arbil Acikalim; Bulent Kaya; Bermal Hasbay Bicer; Mehmet Ulker; Orhan Demircan; Aysun Uguz; Mustafa Balal; Gurhan Sakman; Yasar Sertdemir; Refika Karaer; Eda Altun
Journal:  Indian J Endocrinol Metab       Date:  2014-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.